The value of renal scintigraphy in the conservative management of a patient with tuberous sclerosis

Clinical Nuclear Medicine

Volumn 22, Issue 3, 1997, Pages 176-178

  Bongers, Vivian ^a,b   De Klerk, John M H ^a   Lock, M Tycho W T ^a   Beek, Eric J A ^a   Van Rijk, Peter P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; MERTIATIDE TC 99M;

ADULT; ANGIOMYOLIPOMA; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALE; TUBEROUS SCLEROSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; EMBOLIZATION, THERAPEUTIC; HEMANGIOMA; HUMANS; KIDNEY NEOPLASMS; MALE; RADIOISOTOPE RENOGRAPHY; TECHNETIUM TC 99M MERTIATIDE; TUBEROUS SCLEROSIS;

EID: 0030889270     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199703000-00008     Document Type: Article

References (2)

1. Shepherd CW, Gomez MR, Lie JT, et al.: Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66:792, 1991.
2. Oesterling JE, Fishman EK, Goldman SM, et al.: The management of renal angiomyolipoma. J Urol 135:1121, 1986.